Phd Candidate
CurrentThe main project of this PhD is focused on using a neutrophil-stimulating, bi-specific antibody as a vehicle for organic, immuno-active payloads in order to treat a variety of cancers in pre-clinical models. This involves molecular techniques such as bi-specific antibody design/production, genetic cloning, binding- and ELISA assays; as well as functional.